Scribe Therapeutics, Inc.
As seen on the 24/7 Wall St. homepage on July 2, 2026.
Scribe Therapeutics, Inc.
SCTX · Nasdaq
CRISPR gene-editing startup Scribe Therapeutics officially registered its IPO with the SEC, clearing the way to go public on Nasdaq under ticker SCTX as the biotech sector reopens to emerging therapies.
Mentioned: SCTX